Advertisement
News
Advertisement

Avedro scores FDA advancement for eye disease treatment

Mon, 09/12/2011 - 8:37am
Mass High Tech: The Journal of New England Technology

Waltham ophthalmologic device and pharmaceutical developer Avedro Inc. has been granted orphan drug designation by the U.S. Food and Drug Administration for its treatment of keratoconus, a degenerative eye disease found to be the leading cause of corneal transplants in the U.S.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading